A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of EH002 Gene Therapy for Otoferlin Gene Mutation-mediated Hearing Loss — Stella

Recruiting

Back to DFNB9 trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

China

The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan

Eye & ENT Hospital of Fudan University, Shanghai, Shanghai Municipality

Key details

Sponsor

Yilai Shu

Enrollment target

~24 participants

Started

November 2024

Primary completion

November 2027

Age range

6 Months and older

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov